Stay updated on Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedThe notice about lapse in government funding and operating status has been removed from the page, while all study-related information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe new screenshot shows only cosmetic layout adjustments with no changes to core study details (title, eligibility, endpoints, locations).SummaryDifference0.4%

- Check50 days agoChange DetectedThe page now communicates a funding-related operating-status notice and that the NIH Clinical Center is open, along with a version upgrade to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check57 days agoChange DetectedAdded a new version label (v3.1.0) and removed several MedlinePlus drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older version note (v3.0.2).SummaryDifference0.5%

- Check71 days agoChange DetectedUpdated Revision from v3.0.1 to v3.0.2; removed the Back to Top link. This is a minor update with no changes to core content, pricing, stock, or dates.SummaryDifference0.2%

- Check79 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.